Back to Search Start Over

Oral Vaccines Against Cholera

Authors :
Binod Sah
Sachin N. Desai
John D. Clemens
Sunheang Shin
Source :
Clinical Infectious Diseases. 52:1343-1349
Publication Year :
2011
Publisher :
Oxford University Press (OUP), 2011.

Abstract

The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global burden has returned cholera to the forefront of global public health discussions. Improved water and sanitation should continue to be the mainstays of cholera-prevention efforts, but major improvements are a far-off goal for much of the cholera-affected developing world. The advent of safe and effective, new-generation oral vaccines against cholera has created renewed interest in the use of vaccines as a tool to control cholera.

Details

ISSN :
15376591 and 10584838
Volume :
52
Database :
OpenAIRE
Journal :
Clinical Infectious Diseases
Accession number :
edsair.doi.dedup.....b0acd5730d544e38c38da5c83f5510b6
Full Text :
https://doi.org/10.1093/cid/cir141